Neurology Central

World’s first iPS trial approved in Japan for spinal cord injuries

Earlier this week, Japan’s health ministry approved the world’s first clinical trial for the treatment of spinal cord injuries using induced pluripotent stem cells (iPS), according to a report from The Japan Times.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.